{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:59:23Z","timestamp":1785387563944,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Programmed death-1 (PD-1) inhibitors are increasingly used in neoadjuvant therapy for low rectal cancer, but complete response and toxicity remain heterogeneous. We developed and validated an albumin-based immune-nutritional score (ABINS) to capture host factors not reflected by tumor biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This multicenter retrospective study included 480 consecutive patients with low rectal adenocarcinoma (\u22645 cm from the anal verge) treated with neoadjuvant PD-1-based therapy at three tertiary centers from 2018 to 2023. Patients were assigned to a training cohort (n=276), internal validation cohort (n=87), and geographically separate external validation cohort (n=117). ABINS assigned one point each for albumin &amp;lt;35 g\/L, lymphocyte count &amp;lt;1.0\u00d710\n                      <jats:sup>9<\/jats:sup>\n                      \/L, C-reactive protein &amp;gt;10 mg\/L, total cholesterol &amp;lt;3.6 mmol\/L, and sex-specific anemia, yielding favorable (0\u20131), intermediate (2), and poor (3\u20135) categories. The primary endpoint was composite complete response, defined as sustained clinical complete response under watch-and-wait or pathological complete response. Secondary endpoints included organ preservation, toxicity, immune-related adverse events, and disease-free survival. Logistic and Cox regression evaluated associations, and model performance was assessed by AUC, calibration, and Brier score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 480 patients, 166 (34.6%) achieved composite complete response, 280 (58.3%) achieved organ preservation, and 225 disease-free survival events occurred over a median follow-up of 32.4 months. ABINS classified 333 patients (69.4%) as favorable, 87 (18.1%) as intermediate, and 60 (12.5%) as poor. Complete response decreased stepwise across these groups (42.9%, 20.7%, and 8.3%; P&amp;lt;0.001), as did organ preservation (66.4%, 51.7%, and 23.3%; P&amp;lt;0.001), whereas grade \u22653 toxicity increased (7.5%, 19.5%, and 23.3%; P&amp;lt;0.001). After multivariable adjustment, each one-point ABINS increase independently predicted lower complete response (OR 0.51, 95% CI 0.41\u20130.65), higher grade \u22653 toxicity (OR 1.75, 95% CI 1.37\u20132.23), and worse disease-free survival (HR 1.42, 95% CI 1.27\u20131.60; all P&amp;lt;0.001). Adding ABINS improved external-cohort AUC from 0.703 to 0.772 and reduced Brier score from 0.190 to 0.161.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ABINS is a simple, inexpensive host immune-nutritional score that improves risk stratification for complete response, organ preservation, toxicity, and survival after neoadjuvant PD-1-based therapy in low rectal cancer. Prospective validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1869143","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:24Z","timestamp":1785385284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An albumin-based immune\u2013nutritional score for predicting complete response, organ preservation, and toxicity after neoadjuvant PD-1-based therapy in low rectal cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Ya\u2019nan","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"An","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shijiazhuang People\u2019s Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Second Affiliated Hospital of Xingtai Medical College","place":["Xingtai, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Hebei General Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50903","article-title":"Organ preservation and survival by clinical response grade in patients with rectal cancer treated with total neoadjuvant therapy: a secondary analysis of the OPRA randomized clinical trial","volume":"7","author":"Thompson","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404512","article-title":"Nonoperative management of mismatch repair-deficient tumors","volume":"392","author":"Cercek","year":"2025","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer","volume":"390","author":"Chalabi","year":"2024","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41746-025-02268-9","article-title":"Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer","volume":"9","author":"Chen","year":"2026","journal-title":"NPJ Digit Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1039121","article-title":"The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"9","author":"Guven","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411490","article-title":"Multimodal artificial intelligence-based virtual biopsy for diagnosing abdominal lavage cytology-positive gastric cancer","volume":"12","author":"Ding","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16961","article-title":"The CRP-albumin-lymphocyte (CALLY) index is an independent prognostic factor for gastric cancer patients who receive curative treatment","volume":"44","author":"Aoyama","year":"2024","journal-title":"Anticancer Res"},{"key":"B18","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"B19","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ul\u00edbarri","year":"2005","journal-title":"Nutr Hosp"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw016","article-title":"Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab","volume":"27","author":"Ferrucci","year":"2016","journal-title":"Ann Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12916-025-04393-4","article-title":"Radiomics-based ensemble model predicts postoperative recurrence of gastric cancer","volume":"23","author":"Ding","year":"2025","journal-title":"BMC Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508190","article-title":"Interpretable multimodal fusion model enhances postoperative recurrence prediction in gastric cancer","volume":"12","author":"Ding","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1186\/s12885-025-15097-6","article-title":"Prognostic value of controlling nutritional status score (CONUT) in patients with colorectal cancer: a systematic review and meta-analysis","volume":"25","author":"Gu","year":"2025","journal-title":"BMC Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12885-026-15557-7","article-title":"Clinical significance of the pretreatment C-reactive protein-albumin-lymphocyte (CALLY) index in colorectal cancer patients: a meta-analysis","volume":"26","author":"Pang","year":"2026","journal-title":"BMC Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci Rep"},{"key":"B29","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T-cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress antitumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/s41467-026-71347-6","article-title":"A deep learning-based digital biopsy for predicting early recurrence in gastric cancer","volume":"17","author":"Ding","year":"2026","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0041","article-title":"NCCN guidelines insights: rectal cancer, version 3.2024","volume":"22","author":"Benson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:25Z","timestamp":1785385285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1869143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1869143"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1869143","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1869143"}}